Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.4081/monaldi.2021.1867 http://scihub22266oqcxt.onion/10.4081/monaldi.2021.1867 34121379!ä!34121379 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 263.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 263.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 263.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 263.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Monaldi+Arch+Chest+Dis 2021 ; 91 (4): ä Nephropedia Template TP {{tp|p=34121379|t=2021. Hyperimmune plasma infusion in an immunocompromised Covid-19 patient previously treated for follicular lymphoma |pdf=|usr=}}{{34121379}} gab.com Text Hyperimmune plasma infusion in an immunocompromised Covid-19 patient previously treated for follicular lymphoma JO: Monaldi Arch Chest Dis http://www.kidney.de/pget.php?&tw=1&pmid=34121379 #FOAvip Covid-19 in immunocompromised patients shows a prolonged course and may lead to a poor prognosis. Although data on hyperimmune plasma for treatment of Covid-19 suggest an improved outcome in immunocompetent patients, limited data are currently available in immunocompromised patients. We present the case of a 62-year-old Caucasian woman, who was previously treated with obinutuzumab and bendamustine for follicular lymphoma and showed a prolonged positive test for Covid-19. Since no improvement was observed with standard of care (including remdesivir), the possibility of hyperimmune plasma infusion was discussed. A first dose of hyperimmune plasma was administered, with subsequent onset of fever, increasing inflammatory indexes and worsening radiological findings. Three days later a second dose of plasma was administered. Within twelve hours cough and fever disappeared, and oxygen at rest was discontinued. The patient was discharged 5 days later, and nasopharyngeal swabs resulted negative 16 days after discharge. Twit Text FOAVip Hyperimmune plasma infusion in an immunocompromised Covid-19 patient previously treated for follicular lymphoma ????Monaldi Arch Chest Dis http://www.kidney.de/pget.php?&tw=1&pmid=34121379 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34121379 #FOAvip English Wikipedia <ref>{{Cite pmid|34121379}}</ref> Hyperimmune plasma infusion in an immunocompromised Covid-19 patient previously treated for follicular lymphoma #MMPMID34121379 Levi G; Rocchetti C; Magri R; Uccelli S; Bottone D; Quadri F; Novali M; Santin AD; Bezzi M Monaldi Arch Chest Dis 2021[Jun]; 91 (4): ä PMID34121379show ga Covid-19 in immunocompromised patients shows a prolonged course and may lead to a poor prognosis. Although data on hyperimmune plasma for treatment of Covid-19 suggest an improved outcome in immunocompetent patients, limited data are currently available in immunocompromised patients. We present the case of a 62-year-old Caucasian woman, who was previously treated with obinutuzumab and bendamustine for follicular lymphoma and showed a prolonged positive test for Covid-19. Since no improvement was observed with standard of care (including remdesivir), the possibility of hyperimmune plasma infusion was discussed. A first dose of hyperimmune plasma was administered, with subsequent onset of fever, increasing inflammatory indexes and worsening radiological findings. Three days later a second dose of plasma was administered. Within twelve hours cough and fever disappeared, and oxygen at rest was discontinued. The patient was discharged 5 days later, and nasopharyngeal swabs resulted negative 16 days after discharge. |*COVID-19[MESH] |*Lymphoma, Follicular/drug therapy[MESH] |Female[MESH] |Humans[MESH] |Immunocompromised Host[MESH] |Middle Aged[MESH] |SARS-CoV-2[MESH]Hyperimmune plasma infusion in an immunocompromised Covid-19 patient p(epmc).pdf DeepDyve Pubget Overpricing